GlassScriptPhysician profile
Yu Zhong
NPI 1780343764
$1,999.59
in general payments reported to CMS, 2019-2025
11 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $361 · 2023: $246 · 2024: $1,034 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,638.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $606.42 | 2023-2024 | |
| Gilead Sciences, INC. | $274.72 | 2022-2025 | Livdelzi |
| Shockwave Medical, INC | $183.99 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Neurocrine Biosciences, INC. | $158.22 | 2024-2025 | Ingrezza |
| Genentech USA, INC. | $149.41 | 2022 | |
| Amgen INC. | $140.14 | 2024 | Krystexxa |
| Boston Scientific Corporation | $124.17 | 2025 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $121.82 | 2024 | Airsupra |
| Horizon Therapeutics Plc | $86.94 | 2022 | |
| Teleflex LLC | $78.35 | 2024 | Urolift |
| Abiomed | $75.41 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yu Zhong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.